Altered coagulation profile in peripheral artery disease patients. (August 2020)

• Record Type: Journal Article
• Authors: Zamzam, Abdelrahman; Syed, Muzammil H; Rand, Margaret L; Singh, Krishna; Hussain, Mohamad A; Jain, Shubha; Khan, Hamzah; Verma, Subodh; Al-Omran, Mohammed; Abdin, Rawand; Qadura, Mohammad
• Is Part Of: Vascular. Volume 28:Number 4(2020)
• Page Start: 368
• Page End: 377
• Publication Date: 2020-08
• Subjects: Coagulation -- peripheral artery disease -- vascular biology -- thrombosis -- chronic limb threatening ischemia; 616.13
• DOI: 10.1177/1708538120915997
• Languages: English
• ISSNs: 1708-5381

Abstract

Objective: Peripheral artery disease patients have been shown to be more susceptible to thrombotic events compared to non-peripheral artery disease patients. Therefore, the aim of this study was to investigate the coagulation profile in peripheral artery disease patients with chronic limb threatening ischemia, moderate peripheral artery disease patients with claudication, and non-peripheral artery disease controls. Methods: Chronic limb threatening ischemia patients were matched to peripheral artery disease patients with claudication and non-peripheral artery disease controls in a 1:1:1 ratio. Each patient had their cytokines, markers of thrombin generation, coagulation factors, natural anti-coagulants, fibrinolysis, and endothelial injury markers assessed. Results: Markers of thrombin activation, thrombin Fragments F1 + 2 (Frag 1 + 2), and thrombin–anti-thrombin complex were found to be significantly elevated in all peripheral artery disease and chronic limb threatening ischemia patients relative to non-peripheral artery disease controls. Similarly, relative to non-peripheral artery disease controls, inflammatory markers including C-reactive protein, soluble platelet factor 4, and neutrophil gelatinase-associated lipocalin were also found to be significantly upregulated in chronic limb threatening ischemia patients, but not in peripheral artery disease patients with claudication. Furthermore, our data demonstrated significant increases in markers of endothelial injury in chronic limb threatening ischemia patients relative to non-peripheral artery disease controls. Finally, decreases in natural anti-coagulants (protein C and protein S) and coagulation factors FIX, FXI, and FXII were also observed in chronic limb threatening ischemia patients when compared with non-peripheral artery disease controls. Conclusions: Our data suggest that in relation to non-peripheral artery disease controls, chronic limb threatening ischemia patients are more hypercoagulable. However, peripheral artery disease patients with claudication appear to have similar levels of circulating procoagulant markers as non-peripheral artery disease patients. This may explain the increased risk of thrombotic events observed in chronic limb threatening ischemia patients.